<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Approach to the child with anemia</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Approach to the child with anemia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Approach to the child with anemia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jacquelyn M Powers, MD, MS</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Claudio Sandoval, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sarah O'Brien, MD, MSc</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Martin I Lorin, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carrie Armsby, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 12, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The approach to anemia in the pediatric patient is reviewed here. Included are pertinent issues related to the history, physical examination, and initial laboratory work-up; methods for classifying anemia; and algorithms designed to help guide diagnosis.</p><p>A systematic approach to the examination of the peripheral blood smear and bone marrow is discussed separately. (See  <a class="medical medical_review" href="/d/html/4435.html" rel="external">"Evaluation of the peripheral blood smear"</a> and  <a class="medical medical_review" href="/d/html/4434.html" rel="external">"Evaluation of bone marrow aspirate smears"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">DEFINITION OF ANEMIA</span><span class="headingEndMark"> — </span>Anemia is defined as reduced blood hemoglobin (HGB) concentration or red blood cell (RBC) mass:</p><p class="bulletIndent1"><span class="glyph">●</span>Hemoglobin (HGB) – A measure of the RBC pigment HGB concentration, expressed as grams per 100 mL (dL) of whole blood. The reference range for HGB in children ages 6 to 12 years old is approximately 11.2 to 14.5 g/dL (112 to 145 g/L).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hematocrit (HCT) – The fractional volume of whole blood occupied by RBCs, expressed as a percentage. The reference range for HCT in children ages 6 to 12 years old is 35 to 44 percent.</p><p></p><p>Reference ranges for HGB and HCT vary with age and sex  (<a class="graphic graphic_table graphicRef101544" href="/d/graphic/101544.html" rel="external">table 1</a>). The threshold for defining anemia is HGB or HCT at or below the 2.5<sup>th</sup> percentile for age and sex based upon reference data from healthy individuals. Previous reports have described lower values for HGB in Black Americans compared with White Americans (approximately 0.5 to 1 g/dL lower for Black Americans) [<a href="#rid1">1,2</a>]. However, those differences likely reflect health disparities related to social determinants of health. We recommend using the same HGB and HCT thresholds for evaluating anemia in all racial and ethnic groups (ie, we do not assume that a slightly lower value in a Black individual is "normal").</p><p class="headingAnchor" id="H97173986"><span class="h1">PATIENT CHARACTERISTICS</span><span class="headingEndMark"> — </span>Causes of anemia in children vary based upon age at presentation, sex, and ethnicity.</p><p class="headingAnchor" id="H97174663"><span class="h2">Age of patient</span><span class="headingEndMark"> — </span>The age of the patient is important to consider because reference values of hemoglobin (HGB) and hematocrit (HCT) vary with age and because different causes of anemia present at different ages  (<a class="graphic graphic_table graphicRef101544" href="/d/graphic/101544.html" rel="external">table 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Birth to three months</strong> – The most common cause of anemia in young infants is "physiologic anemia," which occurs at approximately six to nine weeks of age. Erythropoiesis decreases dramatically after birth as a result of increased tissue oxygenation, which reduces erythropoietin production [<a href="#rid3">3,4</a>]. In healthy term infants, HGB levels are high (&gt;14 g/dL) at birth and then rapidly decline, reaching a nadir of approximately 10 to 11 g/dL at six to nine weeks of age, which is called "physiologic anemia of infancy" (also called the "physiologic nadir")  (<a class="graphic graphic_figure graphicRef81464" href="/d/graphic/81464.html" rel="external">figure 1</a>) [<a href="#rid5">5,6</a>].</p><p></p><p class="bulletIndent1">Pathologic anemia in newborns and young infants is distinguished from physiologic anemia by any of the following [<a href="#rid3">3</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Anemia (HGB &lt;13.5 g/dL) within the first month of life</p><p class="bulletIndent2"><span class="glyph">•</span>Anemia with lower HGB level than is typically seen with physiologic anemia (ie, &lt;9 g/dL)</p><p class="bulletIndent2"><span class="glyph">•</span>Signs of hemolysis (eg, jaundice, scleral icterus, or dark urine) or symptoms of anemia (eg, irritability or poor feeding)</p><p></p><p class="bulletIndent1">Common causes of pathologic anemia in newborns include blood loss, immune hemolytic disease (ie, Rh or ABO incompatibility), congenital infection, twin-twin transfusion, and congenital hemolytic anemia (eg, hereditary spherocytosis, glucose-6-phosphate dehydrogenase [G6PD] deficiency)  (<a class="graphic graphic_algorithm graphicRef101423" href="/d/graphic/101423.html" rel="external">algorithm 1</a>).</p><p></p><p class="bulletIndent1">Hyperbilirubinemia in the newborn period suggests a hemolytic etiology; microcytosis at birth suggests chronic intrauterine blood loss or thalassemia.</p><p></p><p class="bulletIndent1">Compared with term infants, preterm infants are born with lower HCT and HGB, have shorter red blood cell (RBC) life span, and have impaired erythropoietin production due to immature liver function [<a href="#rid3">3</a>]. Hence, the decline in RBC production occurs earlier after birth and is more severe than the anemia seen in term infants. This is referred to as "anemia of prematurity" and is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/4962.html" rel="external">"Anemia of prematurity (AOP)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infants three to six months</strong> – Anemia detected at three to six months of age suggests a hemoglobinopathy. Nutritional iron deficiency is an unlikely cause of anemia before the age of six months in term infants. (See  <a class="medical medical_review" href="/d/html/7113.html" rel="external">"Diagnosis of sickle cell disorders"</a> and  <a class="medical medical_review" href="/d/html/7116.html" rel="external">"Diagnosis of thalassemia (adults and children)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Toddlers, children, and adolescents</strong> – In toddlers, older children, and adolescents, acquired causes of anemia are more likely, particularly iron deficiency anemia. Screening for iron deficiency anemia is recommended in all children at 9 to 12 months of age. At that age, children who are exclusively breastfed or breastfed without sufficient iron supplementation are at highest risk for iron deficiency. In contrast, infants who primarily receive iron-fortified formula during the first year of life are at risk for iron deficiency after transition to cow milk. Therefore, additional laboratory screening should be considered in children with additional risk factors (eg, excessive cow milk intake in toddlers 12 to 36 months of age, onset of menarche in adolescent females). Recommendations for screening for iron deficiency are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/5925.html" rel="external">"Iron deficiency in infants and children &lt;12 years: Screening, prevention, clinical manifestations, and diagnosis", section on 'Screening recommendations'</a>.)</p><p></p><p class="headingAnchor" id="H97174525"><span class="h2">Sex</span><span class="headingEndMark"> — </span>Some inherited causes of anemia are X-linked (eg, G6PD deficiency and X-linked sideroblastic anemia) and occur most commonly in males. In postmenarchal girls, excessive menstrual bleeding is an important cause of anemia, and clinicians should suspect and evaluate for an underlying bleeding disorder. (See  <a class="medical medical_review" href="/d/html/7111.html" rel="external">"Diagnosis and management of glucose-6-phosphate dehydrogenase (G6PD) deficiency", section on 'Epidemiology'</a> and  <a class="medical medical_review" href="/d/html/116.html" rel="external">"Abnormal uterine bleeding in adolescents: Evaluation and approach to diagnosis", section on 'Causes of heavy menstrual bleeding'</a> and  <a class="medical medical_review" href="/d/html/7122.html" rel="external">"Causes and pathophysiology of the sideroblastic anemias", section on 'X-linked sideroblastic anemia (ALAS2 mutation)'</a>.)</p><p class="headingAnchor" id="H97174476"><span class="h2">Ethnicity</span><span class="headingEndMark"> — </span>Ethnic background can be helpful in guiding the work-up for hemoglobinopathies and enzymopathies (eg, G6PD deficiency). As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>HGB S and C are most commonly seen in individuals of African or Hispanic descent, and Middle Eastern populations. (See  <a class="medical medical_review" href="/d/html/7113.html" rel="external">"Diagnosis of sickle cell disorders"</a> and  <a class="medical medical_review" href="/d/html/445.html" rel="external">"Hemoglobinopathy: Screening and counseling in the reproductive setting and fetal diagnosis", section on 'Epidemiology of carrier state and disease'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Thalassemia syndromes are more common in individuals of Mediterranean and Southeast Asian descent. (See  <a class="medical medical_review" href="/d/html/7116.html" rel="external">"Diagnosis of thalassemia (adults and children)", section on 'Epidemiology'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>G6PD deficiency is more common among Sephardic Jewish individuals; Black individuals from sub-Saharan Africa or Brazil; African Americans; and people from Thailand, Sardinia, Greece, South China, and India (areas where malaria was once endemic)  (<a class="graphic graphic_figure graphicRef129472" href="/d/graphic/129472.html" rel="external">figure 2</a>). (See  <a class="medical medical_review" href="/d/html/7111.html" rel="external">"Diagnosis and management of glucose-6-phosphate dehydrogenase (G6PD) deficiency", section on 'Epidemiology'</a>.)</p><p></p><p class="headingAnchor" id="H366935479"><span class="h1">EVALUATION</span></p><p class="headingAnchor" id="H97169656"><span class="h2">History</span><span class="headingEndMark"> — </span>The evaluation of a child with anemia begins with a thorough history. The degree of symptoms, past medical history, family history, dietary history, and developmental history may provide important clues to the cause of anemia  (<a class="graphic graphic_table graphicRef101543" href="/d/graphic/101543.html" rel="external">table 2</a>):</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Symptoms</strong> – Characterizing the symptoms helps elucidate the severity and chronicity of anemia and may identify patients with blood loss or hemolytic etiologies:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Symptoms attributable to anemia</strong> – Common symptoms of anemia include lethargy, tachycardia, and pallor. Infants may present with irritability and poor oral intake. However, because of the body's compensatory abilities, patients with chronic anemia may have few or no symptoms compared with those with acute anemia at comparable hemoglobin (HGB) levels.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Symptoms of hemolysis</strong> – Changes in urine color, scleral icterus, or jaundice may indicate the presence of a hemolytic disorder. Hemolytic episodes that occur only in male family members may indicate the presence of a sex-linked disorder, such as glucose-6-phosphate dehydrogenase (G6PD) deficiency. (See  <a class="medical medical_review" href="/d/html/5932.html" rel="external">"Overview of hemolytic anemias in children"</a> and  <a class="medical medical_review" href="/d/html/7111.html" rel="external">"Diagnosis and management of glucose-6-phosphate dehydrogenase (G6PD) deficiency", section on 'Clinical manifestations'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Bleeding symptoms</strong> – Specific questions related to bleeding from the gastrointestinal tract, including changes in stool color, identification of blood in stools, and history of bowel symptoms, should be reviewed. It is also important to determine whether there is a personal or family history of inflammatory bowel disease, celiac disease, intestinal polyps, colorectal cancer, hereditary hemorrhagic telangiectasia, von Willebrand disease, platelet disorders, or hemophilia. (See  <a class="medical medical_review" href="/d/html/5904.html" rel="external">"Lower gastrointestinal bleeding in children: Causes and diagnostic approach"</a> and  <a class="medical medical_review" href="/d/html/5936.html" rel="external">"Approach to the child with bleeding symptoms"</a>.)</p><p></p><p class="bulletIndent2">Severe or recurrent epistaxis also may result in anemia from blood loss and iron deficiency. (See  <a class="medical medical_review" href="/d/html/6451.html" rel="external">"Evaluation of epistaxis in children"</a>.)</p><p></p><p class="bulletIndent2">In adolescent girls, menstrual history should be obtained, including duration and amount of bleeding. Severe epistaxis and/or heavy menstrual bleeding should raise suspicion for an underlying bleeding disorder [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/d/html/116.html" rel="external">"Abnormal uterine bleeding in adolescents: Evaluation and approach to diagnosis", section on 'History'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pica</strong> – The presence of pica, the intense craving for nonfood items, should be assessed given its strong association with iron deficiency. In young children, pica may manifest as craving dirt, rocks, and paper. In adolescents, craving for ice, or pagophagia, may be more common.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Past medical history</strong> – The past medical history should focus on characterizing past episodes of anemia and identifying underlying medical conditions:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Birth history</strong> – The birth and neonatal history should include gestational age, duration of birth hospitalization, and history of jaundice (including onset and need for phototherapy) and/or anemia in the newborn period. Results of newborn screening (which typically includes screening for sickle cell disease) should be reviewed. (See  <a class="medical medical_review" href="/d/html/5933.html" rel="external">"Alloimmune hemolytic disease of the newborn: Postnatal diagnosis and management"</a> and  <a class="medical medical_review" href="/d/html/4962.html" rel="external">"Anemia of prematurity (AOP)"</a> and  <a class="medical medical_review" href="/d/html/7113.html" rel="external">"Diagnosis of sickle cell disorders", section on 'Newborn screening'</a> and  <a class="medical medical_review" href="/d/html/7111.html" rel="external">"Diagnosis and management of glucose-6-phosphate dehydrogenase (G6PD) deficiency", section on 'Neonatal jaundice'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>History of anemia</strong> – Previous complete blood counts (CBCs) should be reviewed, and, if prior anemic episodes occurred, they should be characterized (including duration, etiology, therapy, and resolution). Prior episodes of anemia suggest an inherited disorder, whereas anemia in a patient with previously documented normal CBC suggests an acquired etiology. Patients with certain hemoglobinopathies (such as HGB E or the various thalassemias) may have a history of treatment on multiple occasions for an erroneous diagnosis of iron deficiency anemia. (See  <a class="medical medical_review" href="/d/html/7116.html" rel="external">"Diagnosis of thalassemia (adults and children)"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Underlying medical conditions</strong> – Past medical history and review of symptoms should be obtained to elucidate chronic underlying infectious or inflammatory conditions that may result in anemia. Travel to/from areas of endemic infection (eg, malaria, hepatitis, tuberculosis) should be noted (the Centers for Disease Control and Prevention provides updated information on <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.cdc.gov%2Fmalaria%2Ftravelers%2Fcountry_table%2Fa.html&amp;token=Kw0lYaSzYZYCz0dVW5oNq8KoR4uoG6mzz8%2BOOB1XUAh%2FZ4MBiCR4qBJWOIK%2F%2FC5gcj%2FC7vlu6yJbedKgZrpjew%3D%3D&amp;TOPIC_ID=5927" target="_blank">malaria</a> and <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwwwnc.cdc.gov%2Ftravel%2Fyellowbook%2F2014%2Fchapter-3-infectious-diseases-related-to-travel%2Ftuberculosis&amp;token=CFXBHFK1keNh7o52tsjc8iRUmJf9206MZpvalZWLqbMulQiec5BSql2slCtQkqvQd%2FbwbcKh8liPZiT%2BCoQrQLZKLViGsMn9DS4F8WLFZq0lQZVbspO8TyZy1L%2BQoWz7&amp;TOPIC_ID=5927" target="_blank">tuberculosis</a>). Recent illnesses should be reviewed to investigate for possible infectious etiologies of anemia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Drug and toxin exposure</strong> – Current and past medications (including homeopathic or herbal supplements) should be reviewed with particular attention to oxidant drugs that can cause hemolysis, particularly in patients with underlying G6PD deficiency (eg, drugs such as fluoroquinolones, <a class="drug drug_pediatric" data-topicid="13205" href="/d/drug information/13205.html" rel="external">dapsone</a>, <a class="drug drug_pediatric" data-topicid="12645" href="/d/drug information/12645.html" rel="external">nitrofurantoin</a>, and sulfonylureas; foods such as fava beans; and others, as summarized in the table  (<a class="graphic graphic_table graphicRef74254" href="/d/graphic/74254.html" rel="external">table 3</a>)). Possible environmental toxin exposure should be explored, including lead exposure and nitrates in well water. (See  <a class="medical medical_review" href="/d/html/7111.html" rel="external">"Diagnosis and management of glucose-6-phosphate dehydrogenase (G6PD) deficiency", section on 'Inciting drugs, chemicals, foods, illnesses'</a> and  <a class="medical medical_review" href="/d/html/6493.html" rel="external">"Childhood lead poisoning: Exposure and prevention"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Family history</strong> – Family history of anemia should be reviewed in depth. Family members with jaundice, gallstones, or splenomegaly should be identified. Asking if family members have undergone cholecystectomy or splenectomy may aid in the identification of additional individuals with inherited hemolytic anemias. (See  <a class="medical medical_review" href="/d/html/5932.html" rel="external">"Overview of hemolytic anemias in children", section on 'Intrinsic hemolytic anemias'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dietary history</strong> – The dietary history is focused on assessing iron intake and, to a lesser degree, folate and <a class="drug drug_pediatric" data-topicid="13187" href="/d/drug information/13187.html" rel="external">vitamin B12</a> content.</p><p></p><p class="bulletIndent1">For infants and toddlers, the type of diet, type of formula (if iron fortified), and age of infant at the time of discontinuation of formula or breast milk should be documented. In addition, the amount and type of milk the patient is drinking should be determined. Infants and children who are exclusively fed goat milk can develop anemia due to folate deficiency [<a href="#rid8">8-10</a>]. Exclusively breastfed infants who do not receive sufficient iron supplementation may be anemic at the time of the initial screening at age 9 to 12 months, whereas infants receiving iron-fortified formula until age 12 months are unlikely to be anemic at this time, though they may be at risk for iron deficiency during the second year of life after transitioning to cow's milk. Pica (particularly pagophagia, the eating of ice) may suggest lead poisoning and/or iron deficiency. (See  <a class="medical medical_review" href="/d/html/5925.html" rel="external">"Iron deficiency in infants and children &lt;12 years: Screening, prevention, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/7153.html" rel="external">"Causes and pathophysiology of vitamin B12 and folate deficiencies"</a> and  <a class="medical medical_review" href="/d/html/6491.html" rel="external">"Childhood lead poisoning: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1">In older children and adolescents, it is important to ask about special dietary practices (eg, vegetarian or vegan diet), junk food intake, and picky eating habits. Additional details of dietary screening for iron deficiency are provided separately. (See  <a class="medical medical_review" href="/d/html/5350.html" rel="external">"Iron requirements and iron deficiency in adolescents"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Developmental history</strong> – Parents/caregivers should be asked questions to determine if the child has reached age-appropriate developmental milestones. Developmental delay can be associated with iron deficiency, lead toxicity, <a class="drug drug_pediatric" data-topicid="13187" href="/d/drug information/13187.html" rel="external">vitamin B12</a>/<a class="drug drug_pediatric" data-topicid="13322" href="/d/drug information/13322.html" rel="external">folic acid</a> deficiency, and Fanconi anemia [<a href="#rid11">11</a>]. (See  <a class="medical medical_review" href="/d/html/615.html" rel="external">"Developmental-behavioral surveillance and screening in primary care", section on 'Approach to surveillance'</a>.)</p><p></p><p class="headingAnchor" id="H97169928"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>The physical examination also may provide important clues to the cause of anemia. Particular focus should be directed to examination of the skin, eyes, mouth, facies, chest, hands, and abdomen  (<a class="graphic graphic_table graphicRef50361" href="/d/graphic/50361.html" rel="external">table 4</a>).</p><p>Pallor is assessed by examining sites where capillary beds are visible (eg, conjunctiva, palm, and nail beds). However, the sensitivity of clinical assessment of pallor in these locations in detecting severe anemia (ie, HGB &lt;7 g/dL) is only approximately 50 to 60 percent [<a href="#rid12">12-14</a>].</p><p>Patients with hemolytic processes resulting in anemia may present with signs of scleral icterus, jaundice, and hepatosplenomegaly resulting from increased red cell destruction. However, as with the clinical detection of anemia through evaluation of pallor, clinical detection of jaundice often is poor. As an example, in an emergency department setting, the clinical detection of jaundice was found to have sensitivity and specificity of only approximately 70 percent [<a href="#rid15">15</a>].</p><p class="headingAnchor" id="H97170031"><span class="h2">Laboratory evaluation</span><span class="headingEndMark"> — </span>Initial laboratory studies include a CBC with red blood cell (RBC) indices and review of the peripheral blood smear. A reticulocyte count should be obtained, although this is not necessary for the diagnosis of iron deficiency anemia in children &lt;2 years old who present with a mild microcytic anemia and a suggestive dietary history. (See  <a class="medical medical_review" href="/d/html/5925.html" rel="external">"Iron deficiency in infants and children &lt;12 years: Screening, prevention, clinical manifestations, and diagnosis", section on 'Evaluation for suspected iron deficiency anemia'</a>.)</p><p>The CBC, RBC indices, blood smear, and reticulocyte count are used to focus the diagnostic considerations and guide further testing to confirm the etiology of anemia  (<a class="graphic graphic_algorithm graphicRef101548" href="/d/graphic/101548.html" rel="external">algorithm 2</a> and <a class="graphic graphic_algorithm graphicRef101546" href="/d/graphic/101546.html" rel="external">algorithm 3</a>). (See <a class="local">'Diagnostic approach'</a> below.)</p><p class="headingAnchor" id="H97172538"><span class="h3">Complete blood count</span><span class="headingEndMark"> — </span>The CBC provides information about the RBCs and other cell lines (ie, white blood cells [WBCs] and platelets). All three cell lines should be evaluated for abnormalities.</p><p class="headingAnchor" id="H97175577"><span class="h4">Hemoglobin and hematocrit</span><span class="headingEndMark"> — </span>Reference ranges for HGB and hematocrit (HCT) vary with age, so it is important to use age- and sex-adjusted ranges  (<a class="graphic graphic_figure graphicRef81464" href="/d/graphic/81464.html" rel="external">figure 1</a> and <a class="graphic graphic_table graphicRef101544" href="/d/graphic/101544.html" rel="external">table 1</a>).</p><p>Falsely elevated results may be obtained when HGB and HCT values are measured using capillary samples (eg, finger or heel "sticks"), particularly when using microhematocrit measurements, although the likelihood of masking significant anemia is low [<a href="#rid16">16-18</a>]. Spurious results may also occur with automated counters in the presence of lipemia, hemolysis, leukocytosis (with WBC counts &gt;50 × 10<sup>9</sup>/L), or high immunoglobulin levels [<a href="#rid1">1</a>].</p><p class="headingAnchor" id="H97175583"><span class="h4">Red blood cell indices</span><span class="headingEndMark"> — </span>The RBC indices are an integral part of the evaluation of the anemic child. These include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mean corpuscular volume (MCV)</strong> – MCV is measured directly by automated blood cell counters and represents the mean value (in femtoliters [fL]) of the volume of individual RBCs in the blood sample. Reference values for MCV vary based upon age (infants have increased MCV compared with older children)  (<a class="graphic graphic_table graphicRef101544" href="/d/graphic/101544.html" rel="external">table 1</a>). A useful rule of thumb to remember approximate age-appropriate lower reference limits for MCV values is 70 + age in years.</p><p></p><p class="bulletIndent1">MCV is the most useful RBC parameter when evaluating a patient with anemia and is used to classify the anemia as microcytic (ie, ≤2.5<sup>th</sup> percentile), normocytic, or macrocytic (ie, ≥97.5<sup>th</sup> percentile), as discussed below. (See <a class="local">'Microcytic anemia'</a> below and <a class="local">'Normocytic anemia'</a> below and <a class="local">'Macrocytic anemia'</a> below.)</p><p></p><p class="bulletIndent1">Because reticulocytes have a greater MCV than do mature cells  (<a class="graphic graphic_picture graphicRef67042" href="/d/graphic/67042.html" rel="external">picture 1</a>), patients with significant degrees of reticulocytosis may have elevated MCV values in the face of otherwise normocytic RBCs [<a href="#rid19">19</a>]. (See <a class="local">'Macrocytic anemia'</a> below and  <a class="medical medical_review" href="/d/html/7166.html" rel="external">"Macrocytosis/Macrocytic anemia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Red cell distribution width (RDW)</strong> – The RDW is a quantitative measure of the variability of RBC sizes in the sample (anisocytosis). Reference values vary little with age and are generally between 12 and 14 percent [<a href="#rid16">16</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mean corpuscular hemoglobin concentration (MCHC)</strong> – The MCHC is a calculated index (MCHC = HGB/HCT) yielding a value of grams of HGB per 100 mL of RBC. MCHC values vary depending upon the age (infants have higher values than older children) and sex (males have slightly higher values than females) of the child. MCHC also increases with decreasing gestational age [<a href="#rid20">20</a>]. MCHC measurements may vary slightly based upon the technology used and should be interpreted using the reference range for the specific laboratory.</p><p></p><p class="bulletIndent1">The MCHC provides a quantitative assessment of the degree of hypo- or hyperchromia (MCHC ≤32 and ≥35 g/dL, respectively). Hypochromia and hyperchromia usually can be appreciated on the peripheral smear  (<a class="graphic graphic_picture graphicRef64267" href="/d/graphic/64267.html" rel="external">picture 2</a> and <a class="graphic graphic_picture graphicRef70611" href="/d/graphic/70611.html" rel="external">picture 3</a>) [<a href="#rid21">21</a>].</p><p></p><p class="headingAnchor" id="H97172681"><span class="h4">White blood count and platelet count</span><span class="headingEndMark"> — </span>The other cell lines may provide clues to the underlying cause of anemia  (<a class="graphic graphic_algorithm graphicRef101546" href="/d/graphic/101546.html" rel="external">algorithm 3</a>). Leukocytosis (high total WBC count) most commonly suggests an infectious etiology or, less commonly, an acute leukemia. Hypersegmented neutrophils suggest <a class="drug drug_pediatric" data-topicid="13187" href="/d/drug information/13187.html" rel="external">vitamin B12</a> deficiency. Thrombocytosis (high platelet count) is a common finding in iron deficiency [<a href="#rid22">22</a>], and it also frequently occurs as part of the acute phase reaction in response to infection and other inflammatory conditions, particularly Kawasaki disease. (See  <a class="medical medical_review" href="/d/html/8381.html" rel="external">"Approach to the patient with neutrophilia"</a> and  <a class="medical medical_review" href="/d/html/6417.html" rel="external">"Kawasaki disease: Clinical features and diagnosis"</a>.)</p><p>Leukopenia, neutropenia, and/or thrombocytopenia may signify abnormal bone marrow function or increased peripheral destruction of blood cells:</p><p class="bulletIndent1"><span class="glyph">●</span>Causes of bone marrow suppression/failure include transient suppression due to viral infection, drugs or toxins, nutritional deficiency (eg, <a class="drug drug_pediatric" data-topicid="13322" href="/d/drug information/13322.html" rel="external">folic acid</a> or <a class="drug drug_pediatric" data-topicid="13187" href="/d/drug information/13187.html" rel="external">vitamin B12</a> deficiency and, rarely, iron deficiency), acute leukemia, or aplastic anemia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Increased peripheral destruction of blood cells may be due to splenic hyperfunction ("hypersplenism"), microangiopathic hemolytic anemia (eg, hemolytic uremic syndrome), or an autoimmune process (eg, systemic lupus erythematosus, Evans syndrome, autoimmune lymphoproliferative disease)</p><p></p><p class="headingAnchor" id="H3419817456"><span class="h3">Reticulocyte count</span><span class="headingEndMark"> — </span>Reticulocytes are the youngest red cells in the circulation and are identified by the presence of residual RNA  (<a class="graphic graphic_picture graphicRef67042" href="/d/graphic/67042.html" rel="external">picture 1</a> and <a class="graphic graphic_picture graphicRef74294" href="/d/graphic/74294.html" rel="external">picture 4</a>). When interpreting the reticulocyte count, attention must be paid to the particular reticulocyte parameter reported (percentage versus absolute count). It is often helpful to estimate the corrected reticulocyte count (ie, the reticulocyte count corrected for the degree of anemia). </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reticulocyte percentage</strong> – The reticulocyte is reported as a percentage of the RBC population. After the first few months of life, the reference reticulocyte percentage is the same as that of the adult: approximately 1.5 percent [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Absolute reticulocyte count (ARC)</strong> – The ARC is the product of the total RBC count multiplied by the reticulocyte count percentage:</p><p></p><div class="formulaContainer"><div class="formula"><p class="bulletIndent2">ARC = Percent reticulocytes × RBC count/L</p></div></div><p></p><p class="bulletIndent1">The ARC is calculated and reported by many automated cell counters. ARC is expected to increase in the presence of anemia, although laboratories do not provide reference ranges adjusted for the level of anemia. In a patient with anemia, ARC values within the reference range (&lt;100 × 10<sup>9</sup>/L) generally indicate an inappropriately low erythropoietic response [<a href="#rid23">23</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Corrected reticulocyte count</strong> – Estimating the corrected reticulocyte count can be a useful method to determine whether the bone marrow response to anemia is appropriate. The calculation is based on the measured reticulocyte count, measured hematocrit, and normal hematocrit for the patient's age and sex (normal values for hematocrit are summarized in the table  (<a class="graphic graphic_table graphicRef101544" href="/d/graphic/101544.html" rel="external">table 1</a>)):</p><p></p><p class="bulletIndent2">Corrected reticulocyte count = Measured reticulocyte count [percent] × (measured hematocrit ÷ normal hematocrit for age)</p><p></p><p class="bulletIndent1">A corrected reticulocyte count &lt;2 percent is inappropriately low in the setting of anemia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Interpretation </strong>– The reticulocyte count is an indication of bone marrow erythropoietic activity and is used to classify the bone marrow response to anemia (see <a class="local">'Reticulocyte response'</a> below):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Anemia with a high reticulocyte count reflects an increased erythropoietic response to hemolysis or blood loss</p><p class="bulletIndent2"><span class="glyph">•</span>Anemia with a low or normal reticulocyte count reflects deficient production of RBCs </p><p></p><p class="headingAnchor" id="H97170126"><span class="h3">Blood smear</span><span class="headingEndMark"> — </span>A review of the peripheral smear is an essential part of any anemia evaluation. Even if the patient's RBC indices are within reference range, review of the blood smear may reveal abnormal cells that can help identify the cause of anemia. (See  <a class="medical medical_review" href="/d/html/4435.html" rel="external">"Evaluation of the peripheral blood smear"</a>.)</p><p>The following features should be noted:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>RBC size</strong> – A normal RBC should have the same diameter as the nucleus of a small lymphocyte  (<a class="graphic graphic_picture graphicRef59683" href="/d/graphic/59683.html" rel="external">picture 5</a>). This comparison will help the investigator identify the patient with microcytosis  (<a class="graphic graphic_picture graphicRef64267" href="/d/graphic/64267.html" rel="external">picture 2</a>) or macrocytosis  (<a class="graphic graphic_picture graphicRef74901" href="/d/graphic/74901.html" rel="external">picture 6</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Central pallor</strong> – The normal mature RBC is a biconcave disc  (<a class="graphic graphic_picture graphicRef72999" href="/d/graphic/72999.html" rel="external">picture 7</a>). As a result, RBCs on the peripheral smear demonstrate an area of central pallor, which, in normochromic RBCs, is approximately one-third of the diameter of the cell  (<a class="graphic graphic_picture graphicRef59683" href="/d/graphic/59683.html" rel="external">picture 5</a>). Increased central pallor indicates hypochromic cells, which most often are seen in iron deficiency  (<a class="graphic graphic_picture graphicRef64267" href="/d/graphic/64267.html" rel="external">picture 2</a>) and thalassemia  (<a class="graphic graphic_picture graphicRef56728" href="/d/graphic/56728.html" rel="external">picture 8</a>). On the other hand, spherocytes  (<a class="graphic graphic_picture graphicRef70611" href="/d/graphic/70611.html" rel="external">picture 3</a>) and reticulocytes  (<a class="graphic graphic_picture graphicRef67042" href="/d/graphic/67042.html" rel="external">picture 1</a>) do not display central pallor, because they are not biconcave discs.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fragmented cells</strong> – Although the patient's overall RBC indices may be within reference range, review of the blood smear may reveal the presence of small numbers of fragmented cells, indicating a microangiopathic process (<a class="graphic graphic_picture graphicRef70851" href="/d/graphic/70851.html" rel="external">picture 9</a>). (See  <a class="medical medical_review" href="/d/html/5932.html" rel="external">"Overview of hemolytic anemias in children"</a> and  <a class="medical medical_review" href="/d/html/7168.html" rel="external">"Non-immune (Coombs-negative) hemolytic anemias in adults", section on 'Fragmentation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other features</strong> – Other anemias may be characterized by typical morphologic abnormalities, which may go undetected without inspection of the peripheral smear; these include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Sickle cells, as seen in sickle cell disease  (<a class="graphic graphic_picture graphicRef64449" href="/d/graphic/64449.html" rel="external">picture 10</a>) (see  <a class="medical medical_review" href="/d/html/7113.html" rel="external">"Diagnosis of sickle cell disorders"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Spherocytes  (<a class="graphic graphic_picture graphicRef70611" href="/d/graphic/70611.html" rel="external">picture 3</a>), as seen in hereditary spherocytosis and acute hemolysis, or elliptocytes, as seen in congenital elliptocytosis  (<a class="graphic graphic_picture graphicRef63129" href="/d/graphic/63129.html" rel="external">picture 11</a>) (see  <a class="medical medical_review" href="/d/html/7079.html" rel="external">"Hereditary spherocytosis"</a> and  <a class="medical medical_review" href="/d/html/7087.html" rel="external">"Hereditary elliptocytosis and related disorders"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Stomatocytes, as seen in hereditary or acquired stomatocytosis  (<a class="graphic graphic_picture graphicRef75535" href="/d/graphic/75535.html" rel="external">picture 12</a>) (see  <a class="medical medical_review" href="/d/html/7068.html" rel="external">"Hereditary stomatocytosis (HSt) and hereditary xerocytosis (HX)"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pencil poikilocytes, which can be seen in iron deficiency anemia or thalassemia  (<a class="graphic graphic_picture graphicRef64267" href="/d/graphic/64267.html" rel="external">picture 2</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Target cells, as seen in the various hemoglobinopathies, including thalassemia, as well as in liver disease and post-splenectomy  (<a class="graphic graphic_picture graphicRef80318" href="/d/graphic/80318.html" rel="external">picture 13</a> and <a class="graphic graphic_picture graphicRef56728" href="/d/graphic/56728.html" rel="external">picture 8</a>) (see  <a class="medical medical_review" href="/d/html/7088.html" rel="external">"Burr cells, acanthocytes, and target cells: Disorders of red blood cell membrane"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Bite cells and Heinz bodies  (<a class="graphic graphic_picture graphicRef73790" href="/d/graphic/73790.html" rel="external">picture 14</a>) are seen in hemolytic anemia due to oxidant sensitivity, such as G6PD deficiency (see  <a class="medical medical_review" href="/d/html/7111.html" rel="external">"Diagnosis and management of glucose-6-phosphate dehydrogenase (G6PD) deficiency"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The presence of numerous nucleated RBCs indicates rapid bone marrow turnover and is seen with hemolytic processes  (<a class="graphic graphic_picture graphicRef64449" href="/d/graphic/64449.html" rel="external">picture 10</a> and <a class="graphic graphic_picture graphicRef76666" href="/d/graphic/76666.html" rel="external">picture 15</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>RBC agglutination  (<a class="graphic graphic_picture graphicRef50522" href="/d/graphic/50522.html" rel="external">picture 16</a>) is seen in cold agglutinin hemolytic anemia (see  <a class="medical medical_review" href="/d/html/5934.html" rel="external">"Autoimmune hemolytic anemia (AIHA) in children: Classification, clinical features, and diagnosis", section on 'Cold AIHA'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Howell-Jolly bodies  (<a class="graphic graphic_picture graphicRef60588" href="/d/graphic/60588.html" rel="external">picture 17</a>) are associated with absence or hypofunction of the spleen (see  <a class="medical medical_review" href="/d/html/7134.html" rel="external">"Splenomegaly and other splenic disorders in adults", section on 'Asplenia or hyposplenia'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Basophilic stippling  (<a class="graphic graphic_picture graphicRef71989" href="/d/graphic/71989.html" rel="external">picture 18</a>) is classically seen in lead poisoning and may also be present in thalassemia, sickle cell anemia, and sideroblastic anemia (see  <a class="medical medical_review" href="/d/html/6491.html" rel="external">"Childhood lead poisoning: Clinical manifestations and diagnosis"</a>)</p><p></p><p>The appearance of the patient's leukocytes should also be noted:</p><p class="bulletIndent1"><span class="glyph">●</span>Increases in circulating neutrophils, especially increased numbers of band forms or toxic changes  (<a class="graphic graphic_picture graphicRef70248" href="/d/graphic/70248.html" rel="external">picture 19</a>), or the presence of atypical lymphocytes  (<a class="graphic graphic_picture graphicRef55986" href="/d/graphic/55986.html" rel="external">picture 20</a>) suggest the possibility of infectious or inflammatory conditions (see  <a class="medical medical_review" href="/d/html/8381.html" rel="external">"Approach to the patient with neutrophilia"</a> and  <a class="medical medical_review" href="/d/html/8387.html" rel="external">"Approach to the child with lymphocytosis or lymphocytopenia"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hypersegmented neutrophils  (<a class="graphic graphic_picture graphicRef58820" href="/d/graphic/58820.html" rel="external">picture 21</a>) suggest <a class="drug drug_pediatric" data-topicid="13187" href="/d/drug information/13187.html" rel="external">vitamin B12</a> or folate deficiency</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The presence of early WBC forms (eg, blasts)  (<a class="graphic graphic_picture graphicRef57831" href="/d/graphic/57831.html" rel="external">picture 22</a>) along with anemia should raise the suspicion of leukemia or lymphoma (see  <a class="medical medical_review" href="/d/html/6244.html" rel="external">"Overview of the clinical presentation and diagnosis of acute lymphoblastic leukemia/lymphoma in children"</a>)</p><p></p><p class="headingAnchor" id="H366935830"><span class="h1">DIAGNOSTIC APPROACH</span><span class="headingEndMark"> — </span>The history, physical examination, and initial laboratory tests are used to narrow the diagnostic possibilities and guide further testing.</p><p class="headingAnchor" id="H366935837"><span class="h2">Abnormalities in other cell lines</span><span class="headingEndMark"> — </span>The first step in narrowing the diagnostic possibilities is determining whether the patient has isolated anemia or if other cell lines (ie, white blood cells [WBCs] and platelets) are also abnormal  (<a class="graphic graphic_algorithm graphicRef101546" href="/d/graphic/101546.html" rel="external">algorithm 3</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pancytopenia</strong> – Causes of pancytopenia in children include infection, myelosuppressive medications, leukemia, aplastic anemia, and hypersplenism. (See  <a class="medical medical_review" href="/d/html/7152.html" rel="external">"Aplastic anemia: Pathogenesis, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/6244.html" rel="external">"Overview of the clinical presentation and diagnosis of acute lymphoblastic leukemia/lymphoma in children"</a> and  <a class="medical medical_review" href="/d/html/5928.html" rel="external">"Approach to the child with an enlarged spleen"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anemia with thrombocytopenia</strong> – Causes of anemia associated with low platelet count include hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, and Evans syndrome. Rarely, children with severe iron deficiency anemia may also have thrombocytopenia. (See  <a class="medical medical_review" href="/d/html/89549.html" rel="external">"Overview of hemolytic uremic syndrome in children"</a> and  <a class="medical medical_review" href="/d/html/1331.html" rel="external">"Pathophysiology of TTP and other primary thrombotic microangiopathies (TMAs)"</a> and  <a class="medical medical_review" href="/d/html/7078.html" rel="external">"Warm autoimmune hemolytic anemia (AIHA) in adults", section on 'Evans syndrome'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anemia with thrombocytosis</strong> – Iron deficiency anemia is commonly associated with thrombocytosis but can also be associated with thrombocytopenia [<a href="#rid22">22</a>]. Other causes of anemia associated with elevated platelet count include post-splenectomy anemia and infection or inflammation. (See  <a class="medical medical_review" href="/d/html/5925.html" rel="external">"Iron deficiency in infants and children &lt;12 years: Screening, prevention, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/6682.html" rel="external">"Approach to the patient with thrombocytosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anemia with leukocytosis</strong> – Causes of anemia associated with elevated WBC count include leukemia and infection. (See  <a class="medical medical_review" href="/d/html/6244.html" rel="external">"Overview of the clinical presentation and diagnosis of acute lymphoblastic leukemia/lymphoma in children"</a>.)</p><p></p><p class="headingAnchor" id="H366934738"><span class="h2">Classification of anemia</span><span class="headingEndMark"> — </span>Anemias are classified based upon red blood cell (RBC) size (ie, mean corpuscular volume [MCV]) and the physiologic response of the bone marrow (ie, the reticulocyte response). Approaching the evaluation of an anemic patient using these classification schemes helps to further narrow the diagnostic possibilities  (<a class="graphic graphic_algorithm graphicRef101548" href="/d/graphic/101548.html" rel="external">algorithm 2</a>).</p><p class="headingAnchor" id="H366934803"><span class="h3">Microcytic anemia</span><span class="headingEndMark"> — </span>Microcytic anemia  (<a class="graphic graphic_picture graphicRef64267" href="/d/graphic/64267.html" rel="external">picture 2</a>) is defined as anemia with a low MCV (ie, ≤2.5<sup>th</sup> percentile for age and sex)  (<a class="graphic graphic_table graphicRef101544" href="/d/graphic/101544.html" rel="external">table 1</a>). (See <a class="local">'Red blood cell indices'</a> above.)</p><p>The most common causes of microcytic anemia in children are iron deficiency and thalassemia  (<a class="graphic graphic_algorithm graphicRef101548" href="/d/graphic/101548.html" rel="external">algorithm 2</a>) [<a href="#rid1">1,24</a>].</p><p>The red cell distribution width (RDW) can be helpful in differentiating iron deficiency from thalassemia. Anisocytosis (high RDW) is typical of iron deficiency, whereas the RDW is usually within reference range in patients with thalassemia (though elevated RDW can occur). (See  <a class="medical medical_review" href="/d/html/5925.html" rel="external">"Iron deficiency in infants and children &lt;12 years: Screening, prevention, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/7116.html" rel="external">"Diagnosis of thalassemia (adults and children)"</a>.)</p><p class="headingAnchor" id="H72955905"><span class="h3">Normocytic anemia</span><span class="headingEndMark"> — </span>Normocytic anemia is defined as anemia with an MCV within reference range (ie, between the 2.5<sup>th</sup> and 97.5<sup>th</sup> percentile for age and sex  (<a class="graphic graphic_table graphicRef101544" href="/d/graphic/101544.html" rel="external">table 1</a>)). (See <a class="local">'Red blood cell indices'</a> above.)</p><p>Common causes of normocytic anemia include hemolytic anemias, blood loss, infection, medication, and anemia of chronic disease. Other causes of normocytic anemia include hypothyroidism and chronic kidney disease. Transient erythroblastopenia of childhood is an acquired red cell aplasia that typically presents with a progressive normocytic anemia in otherwise healthy children and is a diagnosis of exclusion. (See  <a class="medical medical_review" href="/d/html/5932.html" rel="external">"Overview of hemolytic anemias in children"</a> and  <a class="medical medical_review" href="/d/html/7149.html" rel="external">"Anemia of chronic disease/anemia of inflammation"</a> and  <a class="medical medical_review" href="/d/html/5931.html" rel="external">"Overview of causes of anemia in children due to decreased red blood cell production", section on 'Transient erythroblastopenia of childhood'</a>.)</p><p class="headingAnchor" id="H366934981"><span class="h3">Macrocytic anemia</span><span class="headingEndMark"> — </span>Macrocytic anemia  (<a class="graphic graphic_picture graphicRef74901" href="/d/graphic/74901.html" rel="external">picture 6</a>) is defined as anemia with a high MCV (ie, ≥97.5<sup>th</sup> percentile for age and sex  (<a class="graphic graphic_table graphicRef101544" href="/d/graphic/101544.html" rel="external">table 1</a>)). (See <a class="local">'Red blood cell indices'</a> above.)</p><p>The most common cause of macrocytosis in children is exposure to certain medications (eg, anticonvulsants, <a class="drug drug_pediatric" data-topicid="13007" href="/d/drug information/13007.html" rel="external">zidovudine</a>, and immunosuppressive agents) [<a href="#rid24">24,25</a>]. Other causes include <a class="drug drug_pediatric" data-topicid="13187" href="/d/drug information/13187.html" rel="external">vitamin B12</a> or folate deficiency, liver disease, Diamond-Blackfan anemia, hypothyroidism, and aplastic anemia  (<a class="graphic graphic_algorithm graphicRef101548" href="/d/graphic/101548.html" rel="external">algorithm 2</a>). Isolated macrocytosis is also commonly seen in children with Down syndrome [<a href="#rid26">26</a>].</p><p class="headingAnchor" id="H72955926"><span class="h3">Reticulocyte response</span><span class="headingEndMark"> — </span>The reticulocyte count is especially helpful in evaluating children with normocytic anemia  (<a class="graphic graphic_algorithm graphicRef101548" href="/d/graphic/101548.html" rel="external">algorithm 2</a> and <a class="graphic graphic_algorithm graphicRef101546" href="/d/graphic/101546.html" rel="external">algorithm 3</a>) (see <a class="local">'Reticulocyte count'</a> above):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>High reticulocyte count</strong> – A high reticulocyte count (&gt;3 percent) reflects an increased erythropoietic response to blood loss or hemolysis  (<a class="graphic graphic_table graphicRef64454" href="/d/graphic/64454.html" rel="external">table 5</a>). Common causes include hemorrhage, autoimmune hemolytic anemia, membranopathies (eg, hereditary spherocytosis), enzymopathies (eg, glucose-6-phosphate dehydrogenase [G6PD] deficiency), hemoglobinopathies (eg, sickle cell disease), and microangiopathic hemolytic anemia (eg, hemolytic uremic syndrome)  (<a class="graphic graphic_algorithm graphicRef101548" href="/d/graphic/101548.html" rel="external">algorithm 2</a> and <a class="graphic graphic_algorithm graphicRef101546" href="/d/graphic/101546.html" rel="external">algorithm 3</a>). (See  <a class="medical medical_review" href="/d/html/5932.html" rel="external">"Overview of hemolytic anemias in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Low or normal reticulocyte count</strong> – A low or normal reticulocyte count reflects deficient production of RBCs (ie, a reduced marrow response to the anemia).</p><p></p><p class="bulletIndent1">Causes of inadequate marrow response include infections, lead poisoning, hypoplastic anemias, transient erythroblastopenia of childhood (TEC), Diamond-Blackfan anemia (which typically presents with macrocytic anemia), drugs (most drugs that decrease erythropoiesis affect other cell lines as well; <a class="drug drug_pediatric" data-topicid="13162" href="/d/drug information/13162.html" rel="external">cisplatin</a> is an example of a medication that can cause isolated suppression of erythropoiesis), and kidney disease  (<a class="graphic graphic_algorithm graphicRef101548" href="/d/graphic/101548.html" rel="external">algorithm 2</a> and <a class="graphic graphic_algorithm graphicRef101546" href="/d/graphic/101546.html" rel="external">algorithm 3</a>). (See  <a class="medical medical_review" href="/d/html/5931.html" rel="external">"Overview of causes of anemia in children due to decreased red blood cell production"</a>.)</p><p></p><p>These two categories are not mutually exclusive, however. Hemolysis can be associated with a low reticulocyte count if there is a concurrent disorder that impairs RBC production (eg, infection). Similarly, anemia due to acute blood loss can be associated with low reticulocyte count if there has not been time for the bone marrow to mount an appropriate reticulocyte response, which typically takes approximately one week.</p><p>In some cases, the reticulocyte count depends on the phase of the illness. As an example, the reticulocyte count is low in a child during the acute phase of TEC or transient bone marrow suppression caused by a viral illness. However, during the recovery phase from these disorders, children may have elevated reticulocyte counts as the bone marrow recovers and responds to the anemia. The absence of scleral icterus, jaundice, and hepatosplenomegaly distinguishes this recovery process from a hemolytic process. (See  <a class="medical medical_review" href="/d/html/5931.html" rel="external">"Overview of causes of anemia in children due to decreased red blood cell production", section on 'Transient erythroblastopenia of childhood'</a>.)</p><p class="headingAnchor" id="H366935287"><span class="h2">Confirmatory testing</span><span class="headingEndMark"> — </span>Once the diagnostic possibilities have been narrowed based upon the MCV and reticulocyte count, confirmatory testing is performed  (<a class="graphic graphic_algorithm graphicRef101548" href="/d/graphic/101548.html" rel="external">algorithm 2</a> and <a class="graphic graphic_algorithm graphicRef101546" href="/d/graphic/101546.html" rel="external">algorithm 3</a>).</p><p>If hemolytic anemia is suspected, testing should include direct antiglobulin test, serum indirect bilirubin, lactate dehydrogenase, and haptoglobin levels. Testing for specific etiologies may include direct antiglobulin test, G6PD deficiency screening test, osmotic fragility, and/or hemoglobin (HGB) analysis/electrophoresis. The diagnostic approach is discussed separately. (See  <a class="medical medical_review" href="/d/html/5932.html" rel="external">"Overview of hemolytic anemias in children", section on 'Diagnostic approach'</a>.)</p><p>If iron deficiency is suspected, additional studies may include iron parameters (eg, serum ferritin). Iron studies are not necessary in children &lt;2 years old who present with a mild microcytic anemia and a suggestive dietary history. A therapeutic trial of iron may be used to confirm the diagnosis in these children. (See  <a class="medical medical_review" href="/d/html/5925.html" rel="external">"Iron deficiency in infants and children &lt;12 years: Screening, prevention, clinical manifestations, and diagnosis", section on 'Empiric trial of iron therapy'</a>.)</p><p>Testing for other nutritional deficiencies and/or lead poisoning may include serum folate, <a class="drug drug_pediatric" data-topicid="13187" href="/d/drug information/13187.html" rel="external">vitamin B12</a>, and lead levels. (See  <a class="medical medical_review" href="/d/html/7155.html" rel="external">"Clinical manifestations and diagnosis of vitamin B12 and folate deficiency"</a> and  <a class="medical medical_review" href="/d/html/6491.html" rel="external">"Childhood lead poisoning: Clinical manifestations and diagnosis"</a>.)</p><p>Bone marrow aspirate and/or biopsy may be necessary to evaluate for leukemia or other diseases of bone marrow failure (eg, aplastic anemia, Diamond-Blackfan anemia).</p><p class="headingAnchor" id="H3325842784"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/111044.html" rel="external">"Society guideline links: Pediatric iron deficiency"</a>.)</p><p class="headingAnchor" id="H366940672"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition of anemia</strong> – The threshold for defining anemia is a hemoglobin (HGB) or hematocrit (HCT) that is ≤2.5<sup>th</sup> percentile for age and sex  (<a class="graphic graphic_table graphicRef101544" href="/d/graphic/101544.html" rel="external">table 1</a>). HGB levels are high (&gt;14 g/dL) at birth and then rapidly decline, reaching a nadir of approximately 10 to 11 g/dL at six to nine weeks of age, which is called "physiologic anemia of infancy"  (<a class="graphic graphic_figure graphicRef81464" href="/d/graphic/81464.html" rel="external">figure 1</a>). (See <a class="local">'Definition of anemia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Common causes by age</strong> – The causes of anemia vary based upon the age at presentation (see <a class="local">'Age of patient'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In neonates and young infants, alloimmune hemolytic disease, infection, and hereditary disorders are most common  (<a class="graphic graphic_algorithm graphicRef101423" href="/d/graphic/101423.html" rel="external">algorithm 1</a>). (See  <a class="medical medical_review" href="/d/html/5933.html" rel="external">"Alloimmune hemolytic disease of the newborn: Postnatal diagnosis and management"</a> and  <a class="medical medical_review" href="/d/html/5932.html" rel="external">"Overview of hemolytic anemias in children", section on 'Intrinsic hemolytic anemias'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In older children, acquired causes of anemia are more likely, particularly iron deficiency anemia (dietary or due to blood loss). (See  <a class="medical medical_review" href="/d/html/5925.html" rel="external">"Iron deficiency in infants and children &lt;12 years: Screening, prevention, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>History and physical examination</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Key historical factors in the assessment of a child with anemia include the severity and onset of symptoms, evidence of jaundice or blood loss (gastrointestinal symptoms and menstrual history), drug and toxin exposure, chronic disease, and family history of anemias or hemoglobinopathy  (<a class="graphic graphic_table graphicRef101543" href="/d/graphic/101543.html" rel="external">table 2</a>). (See <a class="local">'History'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The physical examination should include a careful assessment for pallor, scleral icterus, jaundice, hepatomegaly, and splenomegaly  (<a class="graphic graphic_table graphicRef50361" href="/d/graphic/50361.html" rel="external">table 4</a>). (See <a class="local">'Physical examination'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laboratory evaluation</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The laboratory evaluation begins with a complete blood count (CBC), including red blood cell (RBC) indices, reticulocyte count, and review of the peripheral blood smear. (See <a class="local">'Laboratory evaluation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Examination of the peripheral blood smear may reveal features that suggest a specific cause of anemia and helps to evaluate the possibility of a hematologic malignancy. (See <a class="local">'Blood smear'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Once the diagnostic possibilities have been narrowed based upon RBC indices and reticulocyte response, further confirmatory testing is performed, as summarized in the algorithms and discussed above  (<a class="graphic graphic_algorithm graphicRef101548" href="/d/graphic/101548.html" rel="external">algorithm 2</a> and <a class="graphic graphic_algorithm graphicRef101546" href="/d/graphic/101546.html" rel="external">algorithm 3</a>). (See <a class="local">'Confirmatory testing'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Classification by red cell volume</strong> – The mean corpuscular volume (MCV) provides a preliminary categorization of the anemia, which guides additional testing  (<a class="graphic graphic_algorithm graphicRef101548" href="/d/graphic/101548.html" rel="external">algorithm 2</a> and <a class="graphic graphic_algorithm graphicRef101546" href="/d/graphic/101546.html" rel="external">algorithm 3</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Common causes of microcytic (ie, low MCV) anemia include iron deficiency and thalassemia</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Common causes of normocytic (ie, MCV within reference range) anemia include hemolytic anemias, blood loss, infection, medication, and anemia of chronic disease</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Common causes of macrocytic (ie, high MCV) anemia include medications (eg, antiseizure medications) and deficiency of <a class="drug drug_pediatric" data-topicid="13187" href="/d/drug information/13187.html" rel="external">vitamin B12</a> or folate (see <a class="local">'Classification of anemia'</a> above)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reticulocyte response</strong> – The reticulocyte count distinguishes disorders resulting from rapid destruction or loss of RBCs (hemolysis or bleeding) from disorders resulting in an inability to adequately produce RBCs (ie, bone marrow depression). Hemolysis and bleeding are usually associated with a high reticulocyte count (&gt;3 percent), whereas bone marrow depression is associated with a low reticulocyte count  (<a class="graphic graphic_algorithm graphicRef101548" href="/d/graphic/101548.html" rel="external">algorithm 2</a>). (See <a class="local">'Reticulocyte count'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Brugnara C, Oski FA, Nathan DG. Diagnostic approach to the anemic patient. In: Nathan and Oski's Hematology and Oncology of Infancy and Childhood, 8th ed, Orkin SH, Fisher DE, Look T, Lux SE, Ginsburg D, Nathan DG, et AL (Eds), WB Saunders, Philadelphia 2015. p.293.</li><li><a class="nounderline abstract_t">Cheng CK, Chan J, Cembrowski GS, van Assendelft OW. Complete blood count reference interval diagrams derived from NHANES III: stratification by age, sex, and race. Lab Hematol 2004; 10:42.</a></li><li class="breakAll">Gallagher PG. The neonatal erythrocyte and its disorders. In: Nathan and Oski's Hematology and Oncology of Infancy and Childhood, 8th ed, Orkin SH, Fisher DE, Look T, Lux SE, Ginsburg D, Nathan DG (Eds), WB Saunders, Philadelphia 2015. p.52.</li><li><a class="nounderline abstract_t">Kling PJ, Schmidt RL, Roberts RA, Widness JA. Serum erythropoietin levels during infancy: associations with erythropoiesis. J Pediatr 1996; 128:791.</a></li><li><a class="nounderline abstract_t">Holland BM, Jones JG, Wardrop CA. Lessons from the anemia of prematurity. Hematol Oncol Clin North Am 1987; 1:355.</a></li><li><a class="nounderline abstract_t">Matoth Y, Zaizov R, Varsano I. Postnatal changes in some red cell parameters. Acta Paediatr Scand 1971; 60:317.</a></li><li><a class="nounderline abstract_t">Sandoval C, Dong S, Visintainer P, et al. Clinical and laboratory features of 178 children with recurrent epistaxis. J Pediatr Hematol Oncol 2002; 24:47.</a></li><li><a class="nounderline abstract_t">Collins RA. Goat's milk anemia in retrospect. Am J Clin Nutr 1962; 11:169.</a></li><li><a class="nounderline abstract_t">Turck D. Cow's milk and goat's milk. World Rev Nutr Diet 2013; 108:56.</a></li><li><a class="nounderline abstract_t">Basnet S, Schneider M, Gazit A, et al. Fresh goat's milk for infants: myths and realities--a review. Pediatrics 2010; 125:e973.</a></li><li><a class="nounderline abstract_t">Geller J, Kronn D, Jayabose S, Sandoval C. Hereditary folate malabsorption: family report and review of the literature. Medicine (Baltimore) 2002; 81:51.</a></li><li><a class="nounderline abstract_t">Kalter HD, Burnham G, Kolstad PR, et al. Evaluation of clinical signs to diagnose anaemia in Uganda and Bangladesh, in areas with and without malaria. Bull World Health Organ 1997; 75 Suppl 1:103.</a></li><li><a class="nounderline abstract_t">Stoltzfus RJ, Edward-Raj A, Dreyfuss ML, et al. Clinical pallor is useful to detect severe anemia in populations where anemia is prevalent and severe. J Nutr 1999; 129:1675.</a></li><li><a class="nounderline abstract_t">Montresor A, Albonico M, Khalfan N, et al. Field trial of a haemoglobin colour scale: an effective tool to detect anaemia in preschool children. Trop Med Int Health 2000; 5:129.</a></li><li><a class="nounderline abstract_t">Hung OL, Kwon NS, Cole AE, et al. Evaluation of the physician's ability to recognize the presence or absence of anemia, fever, and jaundice. Acad Emerg Med 2000; 7:146.</a></li><li><a class="nounderline abstract_t">Thomas WJ, Collins TM. Comparison of venipuncture blood counts with microcapillary measurements in screening for anemia in one-year-old infants. J Pediatr 1982; 101:32.</a></li><li><a class="nounderline abstract_t">Daae LN, Hallerud M, Halvorsen S. A comparison between haematological parameters in 'capillary' and venous blood samples from hospitalized children aged 3 months to 14 years. Scand J Clin Lab Invest 1991; 51:651.</a></li><li><a class="nounderline abstract_t">Bellamy GJ, Hinchliffe RF. Venous and skin puncture blood counts compared. Clin Lab Haematol 1988; 10:329.</a></li><li><a class="nounderline abstract_t">d'Onofrio G, Chirillo R, Zini G, et al. Simultaneous measurement of reticulocyte and red blood cell indices in healthy subjects and patients with microcytic and macrocytic anemia. Blood 1995; 85:818.</a></li><li><a class="nounderline abstract_t">Christensen RD, Jopling J, Henry E, Wiedmeier SE. The erythrocyte indices of neonates, defined using data from over 12,000 patients in a multihospital health care system. J Perinatol 2008; 28:24.</a></li><li><a class="nounderline abstract_t">Walters MC, Abelson HT. Interpretation of the complete blood count. Pediatr Clin North Am 1996; 43:599.</a></li><li><a class="nounderline abstract_t">Sandoval C. Thrombocytosis in children with iron deficiency anemia: series of 42 children. J Pediatr Hematol Oncol 2002; 24:593.</a></li><li class="breakAll">Means RT, Glader B. Anemia: General Considerations. In: Wintrobe's Clinical Hematology, 12 ed, Greer JP, Foerster J, Rodgers GM, et al (Eds), Lippincott Williams and Wilkins, Philadelphia 2009. Vol 1, p.784.</li><li class="breakAll">Rapaport SI. Diagnosis of anemia. In: Introduction to hematology, JB Lippincott, Philadelphia 1987. p.15.</li><li><a class="nounderline abstract_t">Pappo AS, Fields BW, Buchanan GR. Etiology of red blood cell macrocytosis during childhood: impact of new diseases and therapies. Pediatrics 1992; 89:1063.</a></li><li><a class="nounderline abstract_t">Wachtel TJ, Pueschel SM. Macrocytosis in Down syndrome. Am J Ment Retard 1991; 95:417.</a></li></ol></div><div id="topicVersionRevision">Topic 5927 Version 39.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Brugnara C, Oski FA, Nathan DG. Diagnostic approach to the anemic patient. In: Nathan and Oski's Hematology and Oncology of Infancy and Childhood, 8th ed, Orkin SH, Fisher DE, Look T, Lux SE, Ginsburg D, Nathan DG, et AL (Eds), WB Saunders, Philadelphia 2015. p.293.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15070217" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Complete blood count reference interval diagrams derived from NHANES III: stratification by age, sex, and race.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15070217" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Complete blood count reference interval diagrams derived from NHANES III: stratification by age, sex, and race.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8648538" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Serum erythropoietin levels during infancy: associations with erythropoiesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3329178" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Lessons from the anemia of prematurity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5579856" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Postnatal changes in some red cell parameters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11902740" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Clinical and laboratory features of 178 children with recurrent epistaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13880603" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Goat's milk anemia in retrospect.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24029787" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Cow's milk and goat's milk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20231186" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Fresh goat's milk for infants: myths and realities--a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11807405" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Hereditary folate malabsorption: family report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9529723" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Evaluation of clinical signs to diagnose anaemia in Uganda and Bangladesh, in areas with and without malaria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10460203" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Clinical pallor is useful to detect severe anemia in populations where anemia is prevalent and severe.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10747273" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Field trial of a haemoglobin colour scale: an effective tool to detect anaemia in preschool children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10691073" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Evaluation of the physician's ability to recognize the presence or absence of anemia, fever, and jaundice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7086621" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Comparison of venipuncture blood counts with microcapillary measurements in screening for anemia in one-year-old infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1810025" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : A comparison between haematological parameters in 'capillary' and venous blood samples from hospitalized children aged 3 months to 14 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3180699" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Venous and skin puncture blood counts compared.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7833482" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Simultaneous measurement of reticulocyte and red blood cell indices in healthy subjects and patients with microcytic and macrocytic anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17972890" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The erythrocyte indices of neonates, defined using data from over 12,000 patients in a multihospital health care system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8649901" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Interpretation of the complete blood count.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12368707" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Thrombocytosis in children with iron deficiency anemia: series of 42 children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12368707" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Thrombocytosis in children with iron deficiency anemia: series of 42 children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12368707" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Thrombocytosis in children with iron deficiency anemia: series of 42 children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1534402" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Etiology of red blood cell macrocytosis during childhood: impact of new diseases and therapies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1825915" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Macrocytosis in Down syndrome.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
